Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring

Abstract From the Canadian patent

Disclosed is a compound of formula (1.0) or a pharmaceutically acceptable salt or solvate thereof. Also disclosed are pharmaceutical compositions comprising a pharmaceutically acceptable carrier and an effective amount of a compound of formula (1.0). Further disclosed is a method of treating allergy (for example asthma) inflammation, hypertension, raised intraocular pressure (such as glaucoma), i.e. a method of lowering intraocular pressure sleeping disorders, states of hyper and hypo motility and acidic secretion of the gastrointestinal tract hypo and hyperactivity of , the central nervous system (for example agitation and, depression) and other CNS disorders (such as Alzheimers …